Tectonic Therapeutic, Inc. — Director's Dealing 2019

Jan 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2019-01-02

Reporting Person: Avruch Steven (VP & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-02	Stock Option (Right to Buy)	$15.65	A	88636	Acquired	2029-01-01	Common Stock (88636)	Direct

Footnotes

F1: 25% of the shares vest on January 2, 2020, and the remaining 75% shall vest in equal monthly installments thereafter over a three-year period.